These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26594858)

  • 21. Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan from 2000 to 2006.
    Yamane Y; Aihara M; Ikezawa Z
    Allergol Int; 2007 Dec; 56(4):419-25. PubMed ID: 17713361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morbidity and Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in United States Adults.
    Hsu DY; Brieva J; Silverberg NB; Silverberg JI
    J Invest Dermatol; 2016 Jul; 136(7):1387-1397. PubMed ID: 27039263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of histologic features of toxic epidermal necrolysis.
    Valeyrie-Allanore L; Bastuji-Garin S; Guégan S; Ortonne N; Bagot M; Roujeau JC; Revuz JE; Wechsler J; Wolkenstein P
    J Am Acad Dermatol; 2013 Feb; 68(2):e29-35. PubMed ID: 22088428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pediatric toxic epidermal necrolysis: an institutional review of patients admitted to an intensive care unit.
    Hamilton GM; Fish J
    J Burn Care Res; 2013; 34(6):e351-8. PubMed ID: 23816996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management.
    Sane SP; Bhatt AD
    J Assoc Physicians India; 2000 Oct; 48(10):999-1003. PubMed ID: 11200928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A clinicotherapeutic analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis with an emphasis on the predictive value and accuracy of SCORe of Toxic Epidermal Necrolysis.
    Bansal S; Garg VK; Sardana K; Sarkar R
    Int J Dermatol; 2015 Jan; 54(1):e18-26. PubMed ID: 25534407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Early Systemic Corticosteroid Therapy with Mortality in Patients with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis: A Retrospective Cohort Study Using a Nationwide Claims Database.
    Morita K; Matsui H; Michihata N; Fushimi K; Yasunaga H
    Am J Clin Dermatol; 2019 Aug; 20(4):579-592. PubMed ID: 31041733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Population-Based Study Using National Health Insurance Database in Korea.
    Yang MS; Lee JY; Kim J; Kim GW; Kim BK; Kim JY; Park HW; Cho SH; Min KU; Kang HR
    PLoS One; 2016; 11(11):e0165933. PubMed ID: 27835661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology and costs of patients with toxic epidermal necrolysis: a 27-year retrospective study.
    Oen IM; van der Vlies CH; Roeleveld YW; Dokter J; Hop MJ; van Baar ME
    J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2444-50. PubMed ID: 26416341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study.
    Barvaliya M; Sanmukhani J; Patel T; Paliwal N; Shah H; Tripathi C
    J Postgrad Med; 2011; 57(2):115-9. PubMed ID: 21654132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upper airway involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Bhullar HK; Aung AK; Graudins L; Ihle J; Gin D; Cleland H; Mei Teh B
    Burns; 2020 May; 46(3):682-686. PubMed ID: 31591001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
    Yang Y; Xu J; Li F; Zhu X
    Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated endocan levels and its association with clinical severity in Stevens-Johnson Syndrome and toxic epidermal necrolysis.
    Syed D; Iqbal O; Mosier M; Mitchell R; Hoppensteadt D; Bouchard C; Fareed J; Gamelli R
    Int Angiol; 2015 Oct; 34(5):483-8. PubMed ID: 25394955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of toxic epidermal necrolysis and Stevens-Johnson syndrome: a 5-year retrospective study.
    Thammakumpee J; Yongsiri S
    J Med Assoc Thai; 2013 Apr; 96(4):399-406. PubMed ID: 23691693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum lactate dehydrogenase is a novel marker for the evaluation of disease severity in the early stage of toxic epidermal necrolysis.
    Yun SJ; Choi MS; Piao MS; Lee JB; Kim SJ; Won YH; Lee SC
    Dermatology; 2008; 217(3):254-9. PubMed ID: 18667824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
    Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
    Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term follow-up of patients treated for toxic epidermal necrolysis.
    Oplatek A; Brown K; Sen S; Halerz M; Supple K; Gamelli RL
    J Burn Care Res; 2006; 27(1):26-33. PubMed ID: 16566534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing mortality outcomes of major burns and toxic epidermal necrolysis in a tertiary burns centre.
    Mahar PD; Wasiak J; Paul E; Watters DA; Kirby J; Gin D; Marsh P; Cleland H
    Burns; 2014 Dec; 40(8):1743-7. PubMed ID: 24814156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis.
    Stella M; Clemente A; Bollero D; Risso D; Dalmasso P
    Burns; 2007 Jun; 33(4):452-9. PubMed ID: 17475410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum bicarbonate as a marker to predict mortality in toxic epidermal necrolysis.
    Yeong EK; Lee CH; Hu FC; M Z W
    J Intensive Care Med; 2011; 26(4):250-4. PubMed ID: 21887862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.